Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS)
Rachel C A Dancer, Dhruv Parekh, Sian Lax, Vijay D'Souza, Shengxing Zheng, Chris R Bassford, Daniel Park, D G Bartis, Rahul Mahida, Alice M Turner, Elizabeth Sapey, Wenbin Wei, Babu Naidu, Paul M Stewart, William D Fraser, Kenneth B Christopher, Mark S Cooper, Fang Gao, David M Sansom, Adrian R Martineau, Gavin D Perkins, David R Thickett, Rachel C A Dancer, Dhruv Parekh, Sian Lax, Vijay D'Souza, Shengxing Zheng, Chris R Bassford, Daniel Park, D G Bartis, Rahul Mahida, Alice M Turner, Elizabeth Sapey, Wenbin Wei, Babu Naidu, Paul M Stewart, William D Fraser, Kenneth B Christopher, Mark S Cooper, Fang Gao, David M Sansom, Adrian R Martineau, Gavin D Perkins, David R Thickett
Abstract
Rationale: Vitamin D deficiency has been implicated as a pathogenic factor in sepsis and intensive therapy unit mortality but has not been assessed as a risk factor for acute respiratory distress syndrome (ARDS). Causality of these associations has never been demonstrated.
Objectives: To determine if ARDS is associated with vitamin D deficiency in a clinical setting and to determine if vitamin D deficiency in experimental models of ARDS influences its severity.
Methods: Human, murine and in vitro primary alveolar epithelial cell work were included in this study.
Findings: Vitamin D deficiency (plasma 25(OH)D levels <50 nmol/L) was ubiquitous in patients with ARDS and present in the vast majority of patients at risk of developing ARDS following oesophagectomy. In a murine model of intratracheal lipopolysaccharide challenge, dietary-induced vitamin D deficiency resulted in exaggerated alveolar inflammation, epithelial damage and hypoxia. In vitro, vitamin D has trophic effects on primary human alveolar epithelial cells affecting >600 genes. In a clinical setting, pharmacological repletion of vitamin D prior to oesophagectomy reduced the observed changes of in vivo measurements of alveolar capillary damage seen in deficient patients.
Conclusions: Vitamin D deficiency is common in people who develop ARDS. This deficiency of vitamin D appears to contribute to the development of the condition, and approaches to correct vitamin D deficiency in patients at risk of ARDS should be developed.
Trial registration: UKCRN ID 11994.
Keywords: ARDS; Innate Immunity.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Figures
References
- Parekh D, Dancer RC, Thickett DR. Acute lung injury. Clin Med 2011;11:615–18. 10.7861/clinmedicine.11-6-615
- van Schoor NM, Lips P. Worldwide vitamin D status. Best Pract Res Clin Endocrinol Metab 2011;25:671–80. 10.1016/j.beem.2011.06.007
- Parekh D, Thickett DR, Turner AM. Vitamin D deficiency and acute lung injury. Inflamm Allergy Drug Targets 2013;12:253–61. 10.2174/18715281113129990049
- Remmelts HH, van de Garde EM, Meijvis SC, et al. . Addition of vitamin d status to prognostic scores improves the prediction of outcome in community-acquired pneumonia. Clin Infect Dis 2012;55:1488–94. 10.1093/cid/cis751
- Cannell JJ, Hollis BW. Use of vitamin D in clinical practice. Altern Med Rev 2008;13:6–20.
- Amrein K, Schnedl C, Holl A, et al. . Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial. JAMA 2014;312:1520–30. 10.1001/jama.2014.13204
- Kempker JA, Tangpricha V, Ziegler TR, et al. . Vitamin D in sepsis: from basic science to clinical impact. Crit Care 2012;16:316 10.1186/cc11252
- Froicu M, Cantorna MT. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol 2007;8:5 10.1186/1471-2172-8-5
- Perkins GD, McAuley DF, Thickett DR, et al. . The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial. Am J Respir Crit Care Med 2006;173:281–7. 10.1164/rccm.200508-1302OC
- Perkins GD, Gates S, Lamb SE, et al. . Beta Agonist Lung Injury TrIal-2 (BALTI-2) trial protocol: a randomised, double-blind, placebo-controlled of intravenous infusion of salbutamol in the acute respiratory distress syndrome. Trials 2011;12:113 10.1186/1745-6215-12-113
- Bernard GR, Artigas A, Brigham KL, et al. . The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149(3 Pt 1):818–24. 10.1164/ajrccm.149.3.7509706
- Nathani N, Perkins GD, Tunnicliffe W, et al. . Kerbs von Lungren 6 antigen is a marker of alveolar inflammation but not of infection in patients with acute respiratory distress syndrome. Crit Care 2008;12:R12 10.1186/cc6785
- Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. . Hypovitaminosis D in Medical Inpatients. N Engl J Med 1998;338:777–83. 10.1056/NEJM199803193381201
- Holick MF. Vitamin D Deficiency. N Engl J Med 2007;357:266–81. 10.1056/NEJMra070553
- O'Kane CM, McKeown SW, Perkins GD, et al. . Salbutamol up-regulates matrix metalloproteinase-9 in the alveolar space in the acute respiratory distress syndrome. Crit Care Med 2009;37:2242–9. 10.1097/CCM.0b013e3181a5506c
- Perkins GD, Gao F, Thickett DR. In vivo and in vitro effects of salbutamol on alveolar epithelial repair in acute lung injury. Thorax 2008;63:215–20. 10.1136/thx.2007.080382
- Lax S, Wilson MR, Takata M, et al. . Using a non-invasive assessment of lung injury in a murine model of acute lung injury. BMJ Open Respir Res 2014;1:e000014 10.1136/bmjresp-2013-000014
- Chishimba L, Thickett DR, Stockley RA, et al. . The vitamin D axis in the lung: a key role for vitamin D-binding protein. Thorax 2010;65:456–62. 10.1136/thx.2009.128793
- Craig TR, Duffy MJ, Shyamsundar M, et al. . Extravascular lung water indexed to predicted body weight is a novel predictor of intensive care unit mortality in patients with acute lung injury. Crit Care Med 2010;38:114–20. 10.1097/CCM.0b013e3181b43050
- Calfee CS, Ware LB, Eisner MD, et al. . Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 2008;63:1083–9. 10.1136/thx.2008.095588
- Eisner MD, Parsons P, Matthay MA, et al. . Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury. Thorax 2003;58:983–8. 10.1136/thorax.58.11.983
- Ware LB, Koyama T, Billheimer DD, et al. . Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 2010;137:288–96. 10.1378/chest.09-1484
- Hewison M. Vitamin D and immune function: an overview. Proc Nutr Soc 2012;71:50–61. 10.1017/S0029665111001650
- Leow L, Simpson T, Cursons R, et al. . Vitamin D, innate immunity and outcomes in community acquired pneumonia. Respirology 2011;16:611–16. 10.1111/j.1440-1843.2011.01924.x
- Mohamed WA, Al-Shehri MA. Cord blood 25-hydroxyvitamin d levels and the risk of acute lower respiratory tract infection in early childhood. J Trop Pediatr 2013;59:29–35. 10.1093/tropej/fms042
- Grant WB. Low vitamin D status may predict women at risk of sepsis associated with delivery. BJOG 2012;119:1018–19; author reply 19–20 10.1111/j.1471-0528.2012.03361.x
- Flynn L, Zimmerman LH, McNorton K, et al. . Effects of vitamin D deficiency in critically ill surgical patients. Am J Surg 2012;203:379–82; discussion 82 10.1016/j.amjsurg.2011.09.012
- Takano Y, Mitsuhashi H, Ueno K. 1alpha,25-Dihydroxyvitamin D(3) inhibits neutrophil recruitment in hamster model of acute lung injury. Steroids 2011;76:1305–9. 10.1016/j.steroids.2011.06.009
- Edelson JD, Chan S, Jassal D, et al. . Vitamin D stimulates DNA synthesis in alveolar type-II cells. Biochim Biophys Acta 1994;1221:159–66. 10.1016/0167-4889(94)90008-6
- Parekh D, Dancer RC, Lax S, et al. . Vitamin D to prevent acute lung injury following oesophagectomy (VINDALOO): study protocol for a randomised placebo controlled trial. Trials 2013;14:100 10.1186/1745-6215-14-100
Source: PubMed